Loading company…
Seeing Medicines develops regenerative cell therapies for macular degenerative diseases.
Founded in 2020 and based in North Carolina, Seeing Medicines develops cellular therapies for age-related macular degeneration, Best Disease, Stargardt Disease, and other macular illnesses. Its lead product is SMI-001, a therapy system for macular degeneration. The company raised nearly USD 7 million in equity funding in June 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in